Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lower Extremity | 5 | 2019 | 93 | 1.190 |
Why?
|
| After-Hours Care | 1 | 2019 | 6 | 0.710 |
Why?
|
| Hospital Costs | 1 | 2019 | 36 | 0.700 |
Why?
|
| Operating Rooms | 1 | 2019 | 32 | 0.700 |
Why?
|
| Patient Care Team | 1 | 2019 | 124 | 0.660 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2014 | 68 | 0.620 |
Why?
|
| Seroma | 1 | 2011 | 3 | 0.410 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 11 | 0.410 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 11 | 0.390 |
Why?
|
| Vena Cava, Inferior | 1 | 2010 | 31 | 0.380 |
Why?
|
| Sarcoma | 1 | 2010 | 56 | 0.370 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 90 | 0.360 |
Why?
|
| Accidental Falls | 1 | 2010 | 204 | 0.330 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2014 | 78 | 0.330 |
Why?
|
| Saphenous Vein | 2 | 2017 | 20 | 0.300 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 241 | 0.290 |
Why?
|
| Aged | 13 | 2019 | 9487 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2019 | 3111 | 0.260 |
Why?
|
| Male | 14 | 2019 | 17807 | 0.240 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2014 | 47 | 0.240 |
Why?
|
| Renal Artery Obstruction | 2 | 2014 | 38 | 0.230 |
Why?
|
| Vascular Patency | 3 | 2017 | 66 | 0.220 |
Why?
|
| Treatment Outcome | 7 | 2017 | 3099 | 0.210 |
Why?
|
| Middle Aged | 10 | 2019 | 10829 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 871 | 0.200 |
Why?
|
| Humans | 16 | 2019 | 29093 | 0.190 |
Why?
|
| Time Factors | 4 | 2019 | 2001 | 0.190 |
Why?
|
| Female | 13 | 2019 | 18164 | 0.190 |
Why?
|
| Models, Economic | 1 | 2019 | 18 | 0.180 |
Why?
|
| Specialization | 1 | 2019 | 30 | 0.180 |
Why?
|
| Cost Savings | 1 | 2019 | 32 | 0.180 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 159 | 0.170 |
Why?
|
| Amputation | 1 | 2018 | 37 | 0.170 |
Why?
|
| Electronic Health Records | 1 | 2019 | 118 | 0.160 |
Why?
|
| Risk Factors | 6 | 2017 | 3531 | 0.160 |
Why?
|
| Psoas Muscles | 1 | 2017 | 19 | 0.160 |
Why?
|
| Hand Strength | 1 | 2017 | 85 | 0.160 |
Why?
|
| Marital Status | 1 | 2017 | 20 | 0.150 |
Why?
|
| Vascular Diseases | 1 | 2017 | 61 | 0.150 |
Why?
|
| Aortography | 2 | 2014 | 16 | 0.150 |
Why?
|
| Sarcopenia | 1 | 2017 | 53 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2017 | 97 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2016 | 45 | 0.150 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2016 | 8 | 0.150 |
Why?
|
| Celiac Artery | 1 | 2016 | 6 | 0.150 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2016 | 12 | 0.150 |
Why?
|
| Angioplasty, Balloon | 1 | 2016 | 33 | 0.140 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 787 | 0.140 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 24 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2016 | 113 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 50 | 0.130 |
Why?
|
| Stents | 2 | 2016 | 171 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 116 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 1218 | 0.130 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 637 | 0.120 |
Why?
|
| Furosemide | 1 | 2014 | 6 | 0.120 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2014 | 10 | 0.120 |
Why?
|
| Renal Circulation | 1 | 2014 | 13 | 0.120 |
Why?
|
| Polyethylene Terephthalates | 1 | 2013 | 3 | 0.120 |
Why?
|
| Aneurysm, Infected | 1 | 2013 | 4 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 162 | 0.120 |
Why?
|
| Rifampin | 1 | 2013 | 7 | 0.120 |
Why?
|
| Renal Artery | 1 | 2014 | 43 | 0.120 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 40 | 0.120 |
Why?
|
| Software | 1 | 2014 | 109 | 0.110 |
Why?
|
| Oxygen | 1 | 2014 | 139 | 0.110 |
Why?
|
| Angioplasty | 1 | 2012 | 31 | 0.110 |
Why?
|
| Anesthesia, General | 1 | 2012 | 29 | 0.110 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 29 | 0.110 |
Why?
|
| Ischemia | 1 | 2012 | 92 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2015 | 283 | 0.100 |
Why?
|
| Edema | 1 | 2011 | 30 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 285 | 0.100 |
Why?
|
| Second-Look Surgery | 1 | 2010 | 3 | 0.100 |
Why?
|
| Phlebography | 1 | 2010 | 26 | 0.100 |
Why?
|
| Hematoma | 1 | 2010 | 23 | 0.100 |
Why?
|
| Reoperation | 1 | 2011 | 203 | 0.090 |
Why?
|
| Balloon Occlusion | 1 | 2010 | 29 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 48 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2010 | 56 | 0.090 |
Why?
|
| Mesentery | 1 | 2009 | 5 | 0.090 |
Why?
|
| Comorbidity | 3 | 2017 | 540 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1379 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2010 | 148 | 0.090 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 91 | 0.090 |
Why?
|
| Necrosis | 1 | 2009 | 53 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 3717 | 0.080 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2006 | 2 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 293 | 0.070 |
Why?
|
| Linear Models | 2 | 2017 | 426 | 0.060 |
Why?
|
| Child | 1 | 2010 | 2219 | 0.060 |
Why?
|
| Registries | 2 | 2017 | 278 | 0.060 |
Why?
|
| Recurrence | 2 | 2016 | 235 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2014 | 87 | 0.060 |
Why?
|
| Logistic Models | 2 | 2017 | 727 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2017 | 2019 | 0.050 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2017 | 11 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 29 | 0.040 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 137 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2017 | 65 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2017 | 21 | 0.040 |
Why?
|
| Cause of Death | 1 | 2017 | 220 | 0.040 |
Why?
|
| Retreatment | 1 | 2016 | 40 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 41 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2017 | 447 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2018 | 466 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 54 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 355 | 0.030 |
Why?
|
| Career Choice | 1 | 2015 | 40 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 368 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 709 | 0.030 |
Why?
|
| Perception | 1 | 2015 | 92 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 896 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2016 | 369 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 631 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 96 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 1362 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1356 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2014 | 169 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 56 | 0.030 |
Why?
|
| North Carolina | 1 | 2017 | 1423 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 246 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 8420 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2108 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 130 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 257 | 0.030 |
Why?
|
| Critical Illness | 1 | 2012 | 87 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 726 | 0.030 |
Why?
|
| Length of Stay | 1 | 2012 | 292 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 525 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 670 | 0.020 |
Why?
|
| United States | 1 | 2015 | 3630 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 1305 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 110 | 0.020 |
Why?
|
| Infant | 1 | 2006 | 969 | 0.010 |
Why?
|